Status:

RECRUITING

COVID-19 Vaccines International Pregnancy Exposure Registry

Lead Sponsor:

Pregistry

Conditions:

Covid19

Eligibility:

FEMALE

18-50 years

Brief Summary

The objective of the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER) is to evaluate obstetric, neonatal, and infant outcomes among women vaccinated during pregnancy with a COVID-...

Detailed Description

Rationale and background: COVID-19 vaccines will be used in pregnant populations. Scientific evidence regarding their safety for pregnant women and the developing fetus is lacking. Objective: The obj...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Vaccinated population:
  • Pregnant at time of enrollment
  • Age ≥18 years at time of enrollment
  • Signed the informed consent form and submitted the baseline module "COVID-19 Vaccination During This Pregnancy"
  • Received at least one dose of a COVID-19 vaccine during pregnancy or within the 30 days prior to the first day of the LMP
  • Resident of a country where a Central Institutional Review Board (IRB) or Ethics Committee provided approval to conduct the study or clearance that approval is not required to conduct the study
  • Efforts will be made to obtain documentary evidence of COVID-19 vaccination.
  • Comparison population:
  • Pregnant at time of enrollment
  • Age ≥18 years at time of enrollment
  • Signed the informed consent form and submitted the minimum required data in the initial baseline questionnaire
  • Have not received a COVID-19 vaccine during pregnancy or within the 30 days prior to the first day of the LMP
  • Resident of a country where a Central IRB or Ethics Committee provided approval to conduct the study or clearance that approval is not required to conduct the study
  • Exclusion criteria:
  • Not pregnant at time of enrollment
  • Age \<18 years at time of enrollment

Exclusion

    Key Trial Info

    Start Date :

    June 1 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    6000 Patients enrolled

    Trial Details

    Trial ID

    NCT04705116

    Start Date

    June 1 2021

    End Date

    December 31 2026

    Last Update

    September 26 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Pregistry

    Los Angeles, California, United States, 90045

    COVID-19 Vaccines International Pregnancy Exposure Registry | DecenTrialz